Compare Cardinal Health Inc (CAH) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Dolby Laboratories, Inc. — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while Dolby Laboratories, Inc. trades at $48.49 (market cap $4.59B). The key difference: Cardinal Health Inc is far larger — about 11.7× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| CAH | DLB | |
|---|---|---|
Market Cap | $53.89B | $4.59B |
Sector | Health | Industrials |
52-Week High | $239.71 | $76.79 |
52-Week Low | $146.04 | $48.51 |
Enterprise Value | $58.87B | $4.04B |
Dividend Yield | 0.89% | 2.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
